[logo.jpg]

 
EMPLOYMENT AGREEMENT AMENDMENT
 
EMPLOYMENT AGREEMENT AMENDMENT (this "Amendment"), effective as of January 1,
2014 (the "Effective Date"), by and among Pharma-Bio Serv, Inc. with its
principal office at 6 Road 696, Dorado, Puerto Rico 00646 (the “Company”),
Pharma-Bio Serv PR, Inc., a wholly-owned subsidiary of the Company
("Pharma-PR"), and Nélida Plaza (“Executive”) (hereinafter “the Parties”).
 
W I T N E S S E T H:
 
WHEREAS, Pharma-PR and Executive have entered into that certain Employment
Agreement, dated December 31, 2009, as such Employment Agreement has been and
may be amended, restated or otherwise modified from time to time (the
"Employment Agreement").  Capitalized terms used but not defined herein shall
have the meaning ascribed to such terms in the Employment Agreement; and
 
WHEREAS, the Company desires to modify the Employment Agreement.
 
NOW THEREFORE,  for good and valuable consideration, the receipt and adequacy of
which is hereby acknowledged, the parties hereto agree as follows:
 
1.  
Section 1 of the Employment Agreement is amended and restated in its entirety as
follows:

 
Subject to the terms and conditions hereinafter set forth, the Company hereby
employs Executive as Chief Operating Officer and Secretary.  Executive shall
have the duties and responsibilities associated with the chief operating officer
and secretary of a public company.  Executive shall report to the
Board.  Executive shall also perform such other duties and responsibilities as
may be determined by the Board, as long as such duties are consistent with the
Bylaws of the Company and applicable law.
 
2.  
Section 3(a) of the Employment Agreement is amended and restated in its entirety
as follows:

 
 
(a)
For her services, the Company shall pay Executive a salary (“Salary”) at the
annual rate of $225,000.  Salary shall be paid in such installments as the
regularly pays its executive officers, but not less frequently than
semi-monthly.  Executive’s salary will be revised annually based upon
performance evaluations following the Company’s performance review process and
subject to the financial status of the Company.

 

 
 

--------------------------------------------------------------------------------

 
 

 
3.  
Section 5(e) of the Employment Agreement is amended and restated in its entirety
as

follows:
 
 
(e)
In the event that the Company terminates this Agreement and Executive’s
employment other than for reasons set forth in Sections 5(a), 5(b), or 5(c):

 
i.  
The Company shall (1) pay to the Executive within 30 days after the date of her
termination (a) a  lump-sum severance payment in an amount equivalent to one (1)
year of her salary at the time of the termination, less legal withholdings, or
the severance established by PR labor law No. 80 of May 30, 1976, known as the
“Wrongful Discharge Act” (“Ley de Despido Injustificado”), whichever amount is
higher; (b) any bonuses that the Executive may have earned up to the date of her
termination, and (c) any unused accrued vacation days, (2) provide Executive one
(1) year health coverage for the Executive and dependents, and (3) provide that
any restricted stock units, options or other similar granted awards held by the
Executive will become vested and exercisable for a three month period following
the termination; and

 
ii.  
The restrictions set forth in Section 7(a) of this Agreement shall terminate
immediately.

 
4.  
A new Section 5(f) shall be added to the Employment Agreement as follows:

 
 
(f)
In the event there is a change in control of the Company in connection with a
sale, merger or acquisition of the Company or the Company ceases to be a public
company, and is no longer subject to the reporting obligations of the Securities
Exchange Act of 1934, as amended, any restricted stock units, options or other
similar granted awards held by the Executive will become vested and exercisable
immediately prior to such event.

 
5.  
The terms of this Amendment regarding the vesting of awards in connection with a
termination or change of control of Company shall supersede any such terms in
the award agreements between the Company and Executive.

 
6.  
Except as expressly amended by the terms of this Amendment and all prior
amendments to the Employment Agreement, the terms of the Employment Agreement
shall remain in effect and are unchanged by this Amendment.

 
[Signatures on Following Page]
 
 
 
 

--------------------------------------------------------------------------------

 

 
IN WITNESS WHEREOF, the parties have executed this Amendment in Dorado, Puerto
Rico, this 17th day of February, 2014.
 
PHARMA-BIO SERV, INC.
By:  /s/ Elizabeth Plaza                       
 
EXECUTIVE:
/s/ Nélida Plaza
Name: Elizabeth Plaza
 
Name: Nélida Plaza
Title: Chairman
 
 
Title: Chief Operating Officer and Secretary
 
PHARMA-BIO SERV PR, INC.
By:  /s/ Pedro Lasanta
Name: Pedro Lasanta
Title:  Chief Financial Officer and Vice-President – Finance and Administration